Together they were awarded about $750,000 to evaluate Garwood’s BioPrax device, which was developed to eliminate bacterial biofilm infections associated with orthopedic implants, the release said. The device uses a cathodic voltage-controlled electrical stimulation to kill bacteria on implants, such as a prosthetic knee.
The grant funding, awarded by the Peer Reviewed Orthopedic Research Program of the Congressionally Directed Medical Research Programs, will allow the team to explore the potential for a new clinical application for the BioPrax technology, the release said. Their goal will be to evaluate how the system can be used to enhance wound healing and infection control for those using prosthetic limbs.
Read more here.
More articles on devices:
HCA launches AR spine surgery program at 2nd, 3rd Florida hospitals
2 CEOs on orthopedic consolidation — Don’t grow for the sake of growth alone
175+ spine, orthopedic surgeons on the move in 2020
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.